glp 1 ckd Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future | Endocrine Frontiers | GLP-1 Receptor Agonists
Description
GIP mediates the incretin effect and glucose tolerance by dual actions on alpha cells and beta cells
appropriate monitoring is recommended
GLP-1 medications still activate the same biological pathways at lower doses, but clinical trials have not evaluated whether sub-therapeutic dosing produces consistent or durable weight loss outcomes
Individual variation: GLP-1 receptor sensitivity varies between individuals
Protein-rich foods can be consumed first in a meal to increase the likelihood of sufficient consumption
